These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 18088236

  • 1. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [Abstract] [Full Text] [Related]

  • 2. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [Abstract] [Full Text] [Related]

  • 3. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
    Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD.
    Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
    [Abstract] [Full Text] [Related]

  • 4. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
    Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA, Finckh A, Lovis C, Mach F, Hochstrasser D, Roux-Lombard P, Gabay C.
    Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
    [Abstract] [Full Text] [Related]

  • 5. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
    Cojocaru IM, Cojocaru M, Burcin C.
    Rom J Intern Med; 2006 Sep; 44(2):165-70. PubMed ID: 17236297
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P, Veres K, Laczik R, Der H, Csipo I, Timar O, Szomjak E, Szegedi G, Szodoray P.
    Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
    [Abstract] [Full Text] [Related]

  • 7. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA, Hadzhimitova V, Ribarov S.
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [Abstract] [Full Text] [Related]

  • 8. Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
    Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado Alves J.
    Rheumatology (Oxford); 2009 Jan; 48(1):26-31. PubMed ID: 19000993
    [Abstract] [Full Text] [Related]

  • 9. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
    Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Triplett DA.
    Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
    [Abstract] [Full Text] [Related]

  • 10. Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease.
    Vuilleumier N, Reber G, James R, Burger D, de Moerloose P, Dayer JM, Roux-Lombard P.
    J Autoimmun; 2004 Dec; 23(4):353-60. PubMed ID: 15571929
    [Abstract] [Full Text] [Related]

  • 11. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 12. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun 09; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 13. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
    Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P.
    Eur Heart J; 2010 Apr 09; 31(7):815-23. PubMed ID: 20176799
    [Abstract] [Full Text] [Related]

  • 14. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome.
    Laczik R, Szodoray P, Veres K, Szomják E, Csípo I, Sipka S, Shoenfeld Y, Szekanecz Z, Soltész P.
    Lupus; 2011 Jun 09; 20(7):730-5. PubMed ID: 21505011
    [Abstract] [Full Text] [Related]

  • 15. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
    Vuilleumier N, Bratt J, Alizadeh R, Jogestrand T, Hafström I, Frostegård J.
    Scand J Rheumatol; 2010 Nov 09; 39(6):447-53. PubMed ID: 20604674
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar 09; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension.
    Türkoğlu O, Bariş N, Kütükçüler N, Senarslan O, Güneri S, Atilla G.
    J Periodontol; 2008 Feb 09; 79(2):332-40. PubMed ID: 18251648
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
    Vuilleumier N, Montecucco F, Spinella G, Pagano S, Bertolotto M, Pane B, Pende A, Galan K, Roux-Lombard P, Combescure C, Dallegri F, Mach F, Palombo D.
    Thromb Haemost; 2013 Apr 09; 109(4):706-15. PubMed ID: 23364307
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.
    Circulation; 2004 Jun 29; 109(25):3164-70. PubMed ID: 15184281
    [Abstract] [Full Text] [Related]

  • 20. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul 29; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.